Jackson Ndegwa

Jackson Ndegwa is the Head of Policy and Advocacy at Kenya AIDS NGOs Consortium (KANCO) coordinating and overseeing strategic and policy planning and implementation. He monitors and coordinates policy priority setting and is responsible for coherent implementation of the Consortium’s new Policy strategy 2013-2015. He has worked in the development field since 2005. He started with KANCO as a Vaccines Development Advocacy Officer from 2011, and rose to be the Policy and Advocacy Manager from July 2014. Before Joining KANCO, Jack served with VSO Nepal in Kathmandu as a Management Advisor with Recovering Nepal - a National Network of Drug Users and Drug Service Organizations in Nepal, and the National Institute of Development Research and Advocacy in Kenya. Previously, he also served as Governance Advisor with SNV –Netherlands Development Organization providing advisory services, knowledge networking and evidence-based advocacy to public sector and civil society organizations in Kenya.   
 
http://www.kanco.org/



Kenya AIDS NGOs Consortium (KANCO) is a national membership network of Non-Governmental Organizations (NGOs), Community Based Organizations (CBOs), Faith Based Organizations (FBOs), Private Sector actors and Research and Learning Institutions involved in or that have interest in HIV and AIDS, Tuberculosis, Maternal and Child Health, and Nutrition interventions in Kenya.

Established in 1990, its membership of over 1,200 is open to all registered public and private sector institutions and organizations.  The organization has implemented immunization advocacy related activities since 2011. KANCO works in partnership with the Ministry of Health through the Unit of Vaccines and Immunization Services, Partners, donors and Civil Society Organizations to increase equitable vaccine coverage in Kenya by identifying barriers to universal vaccine coverage in Kenya and developing advocacy plans to overcome these policy and programmatic constraints.

KANCO's immunisation-related priorities include country ownership and implementation of Kenya’s CYMP 2014 – 2017, the Global Vaccine Action Plan (GVAP), and the Global Action Plan for Pneumonia and Diarrhoea (GAPDD).

Comments